Benzinga | Mar 8, 2021 09:25AM EST

Jefferies Initiates Coverage On Nuvation Bio with Buy Rating, Announces Price Target of $20

Jefferies analyst Michael Yee initiates coverage on Nuvation Bio (NYSE:NUVB) with a Buy rating and announces Price Target of $20.